Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Part 1 and 2”

507 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 507 results

Early research (Phase 1)Study completedNCT05476107
What this trial is testing

SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

Who this might be right for
Healthy Volunteers
Applied Molecular Transport 50
Early research (Phase 1)Looking for participantsNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT06200597
What this trial is testing

A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Almirall, S.A. 92
Early research (Phase 1)Study completedNCT01233895
What this trial is testing

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sanofi 26
Early research (Phase 1)Study completedNCT01148095
What this trial is testing

To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers

Who this might be right for
Part A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80
AstraZeneca 6
Testing effectiveness (Phase 2)Study completedNCT02731573
What this trial is testing

Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery.

Who this might be right for
Postoperative Wound Infection Superficial IncisionalPostoperative Wound Infection Deep Incisional Surgical Site
PolyPid Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Early research (Phase 1)Study completedNCT01101932
What this trial is testing

Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 58
Not applicableStudy completedNCT05266599
What this trial is testing

The Effect of Two Different Root Canal Sealers on Postobturation Pain and Clinical and Radiographical Outcome After Two-year Follow-up

Who this might be right for
Asymptomatic Vital Mandibular Molar Teeth
Ege University 100
Early research (Phase 1)Ended earlyNCT00486265
What this trial is testing

Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)

Who this might be right for
Acute Myelogenous Leukemia
AstraZeneca 47
Early research (Phase 1)Looking for participantsNCT05627232
What this trial is testing

Tazemetostat and Palbociclib With CPX-351for R/R AML

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Thomas Jefferson University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07262619
What this trial is testing

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Who this might be right for
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Eikon Therapeutics 160
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Large-scale testing (Phase 3)Study completedNCT00092768
What this trial is testing

MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Who this might be right for
Osteoarthritis
Organon and Co 500
Early research (Phase 1)Study completedNCT05735249
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

Who this might be right for
Healthy Adult Participants
Arisan Therapeutics, Inc. 94
Testing effectiveness (Phase 2)UnknownNCT05747508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon 85
Early research (Phase 1)Study completedNCT02604914
What this trial is testing

A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06053814
What this trial is testing

NS-050/NCNP-03 in Boys With DMD (Meteor50)

Who this might be right for
Duchenne Muscular Dystrophy
NS Pharma, Inc. 20
Not applicableEnded earlyNCT04630925
What this trial is testing

In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes MellitusDiabetes Mellitus
University of Aarhus 1
Next Page